Physician profile
Michael A Wiles
NPI 1689057648
$615.87
in general payments reported to CMS, 2019-2025
18 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $128 · 2021: $36.92 · 2024: $79.69 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $113.44 | 2020-2025 | |
| Sun Pharmaceutical Industries INC. | $76.01 | 2019-2025 | |
| Alcon Vision LLC | $62.42 | 2019-2025 | Precision 1 |
| Allergan, INC. | $41.46 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $38.24 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $33.91 | 2019-2020 | |
| Optos, INC. | $32.24 | 2019-2021 | |
| Glaukos Corporation | $27.56 | 2025 | Istent Infinite, Idosetr |
| Harrow Eye, LLC | $27.04 | 2025 | Vevye |
| Dompe US, INC. | $24.41 | 2025 | Oxervate |
| Biotissue Holdings INC. | $23.88 | 2019 | |
| Tearlab Corp | $20.22 | 2021 | |
| Sight Sciences, INC. | $18.17 | 2020 | |
| Shire North American Group INC | $17.56 | 2019 | |
| Eyevance Pharmaceuticals LLC | $16.34 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $15.79 | 2024 | Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.59 | 2019 | |
| Katena Products, INC. (Dba Corza Medical) | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wiles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.